Archives Publications

T-Cell Lymphomas (English)

T-cell lymphomas are a diverse group of blood cancers that account for less than 15% of all non-Hodgkin lymphomas and can range from slow-growing to highly aggressive. This resource walks through the most common and uncommon subtypes, including peripheral T-cell lymphomas and cutaneous T-cell lymphomas, along with how each is diagnosed and staged. It covers symptoms, treatment options, and what patients and caregivers can expect throughout the care journey.

Aggressive B-Cell Lymphomas (Burkitt, primary mediastinal B-cell, transformed) (English)

B-cell lymphomas account for 85% of all non-Hodgkin lymphoma and range from slow-growing to fast-moving, aggressive forms. This resource focuses on three less common subtypes: Burkitt lymphoma, primary mediastinal B-cell lymphoma, and transformed lymphoma. It covers how each type develops, who it most often affects, and what patients and caregivers can expect when navigating a diagnosis.

Entendiendo el Linfoma de Hodgkin

Entendiendo el Linfoma de Hodgkin Download Figura 3. Estadificación del LH según el sistema de Lugano. El sistema Lugano clasifica el LH de estadios I (enfermedad limitada) a IV (enfermedad avanzada), según si el cáncer se limita a un solo…

Immunotherapy and Other Targeted Therapies (English)

Immunotherapy works with the body's own immune system to identify and destroy lymphoma cells, offering a more targeted approach than traditional chemotherapy. This resource covers the full range of approved immunotherapy options, including monoclonal antibodies, CAR T-cell therapies, bispecific antibodies, checkpoint inhibitors, and targeted therapies, with details on how each works and which lymphoma subtypes they treat. It also includes a list of therapies currently under investigation and questions to bring to your care team when discussing treatment options.

Immunotherapy and Other Targeted Therapies (Spanish)

Entendiendo la inmunoterapia y otros tratamientos dirigidos Download © 2024 Lymphoma Research Foundation Última actualización en mayo de 2024 Lymphoma Research Foundation publica la serie de hojas informativas Entendiendo el Linfoma y la LLC con el propósito de informar y…

Primary Central Nervous System Lymphoma (PCNS) (English)

Primary central nervous system (CNS) lymphoma is a rare and aggressive form of non-Hodgkin lymphoma that develops in the brain, spinal cord, or eye. This resource covers how it is diagnosed and staged, what treatment options are available, and how care is approached when the disease relapses or becomes refractory. It also includes guidance on self-advocacy, questions to bring to your healthcare team, and an overview of therapies currently under investigation in clinical trials.

Follicular Lymphoma (FL) & Relapsed/Refractory FL (English)

Follicular lymphoma is the most common slow-growing form of non-Hodgkin lymphoma, accounting for about 1 in 5 lymphoma diagnoses in the United States. This resource covers how it is diagnosed and staged, what treatment options are available from first-line therapy through relapsed or refractory disease, and what patients can expect over the course of their care. It also includes guidance on self-advocacy, an overview of therapies under investigation, and questions to bring to your healthcare team.